PANX1 and COVID-19: Analysis of lungs obtained from COVID-19 patients with severe immune-cell-infiltrating pathology and major alveolar wall compromise indicates a significant upregulation of Panx-1 expression in multiple cell types, as predicted from the scRNAseq data.